CVS HEALTH Corp
Strategy in plain words
auto-generated from filingsCVS HEALTH Corp is a wealth-management firm allocating client money, specialised in financials (100% of the long book), running a $212.3M US long book across 33 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: SS SPDR S&P 500 ETF TRUST-US, ISHARES 3-7 YEAR TREASURY BO, ISHARES 1-3 YEAR TREASURY BO, ISHARES 1-5Y INV GRADE CORP, ISHARES CORE U.S. AGGREGATE.
Over the last 9 quarters its long book ran on average 1.2pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/optionsSector allocation
Long book by quarter
What does CVS HEALTH own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| PRU PRUDENTIAL FINANCIAL INC | Financials | 2.7K | $262K | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 7, 2026 | 33 | $212.3M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 9 | $135.3M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 31, 2025 | 3 | $102.9M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 1, 2025 | 3 | $190.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 2, 2025 | 3 | $172.7M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 13, 2025 | 3 | $233.7M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 8, 2024 | 5 | $230.2M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 9, 2024 | 6 | $216.8M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 3, 2024 | 6 | $211.8M | canonical | SEC ↗ |